All news from Anaesthesiology

Association Between Cystatin C and Cumulative Incidence Of Hearing Impairment

According to a study, researchers estimated the association between cystatin C and with the 20-year cumulative incidence of hearing impairment (HI), both as an independent biomarker and as a marker of kidney function, and the 20-year incidence of HI. Data were included for 863 participants aged 48 to 86 years with cystatin C data and no HI at baseline. The study was published in JAMA Otolaryngology-Head & Neck Surgery

Health Insurance in Nepal

Every citizen shall have the right to get basic health care and have equal access to health services. These are the fundamental rights guaranteed in the Constitution of Nepal. Besides, Nepal aims to fulfill its commitment of achieving Goal 3 of the United Nations Sustainable Development Goals, which is ensuring good health and well-being of the people by 2030.

Migraine : Safety and Efficacy Ubrogepant in Second Phase 3 Trial

On the heels of favorable results from the phase 3 ACHIEVE-I trial, which were presented last week at the American Academy of Neurology (AAN) 2018 Annual Meeting, topline results from the phase 3 ACHIEVE-2 trial also show that the novel oral calcitonin gene-related peptide (CGRP) receptor antagonist ubrogepant (Allergan) is safe and effective for treating acute migraine, the company announced.

Asthma: Traffic-related pollution Aggrevates the Condition

New research suggests that long-term exposure to traffic-related pollution significantly increases the risk of pediatric asthma, especially in early childhood. Children living within a football field's length of major roadways had nearly three times the odds of pediatric asthma compared to children who lived four times farther away.

Effectiveness of Lapatinib against Breast Cancer

The breast cancer drug lapatinib which is designed to shrink tumors can sometimes cause them to grow in the lab, according to a new study published in eLife. By understanding the molecular basis of this phenomenon, scientists hope that their findings will lead to safer treatment decision-making and drug design in the future.